SciELO - Scientific Electronic Library Online

 
vol.140 número1Cerámicas mexicanas para cicatrización de piel índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Gaceta médica de México

versão On-line ISSN 2696-1288versão impressa ISSN 0016-3813

Resumo

MARTINEZ-MEDINA, Miguel A. Effect of Shortened Directly Observerd Treatment on Compliance and Cure Rate of Pulmonary Tuberculosis. Gac. Méd. Méx [online]. 2004, vol.140, n.1, pp.1-6. ISSN 2696-1288.

Objective: To evaluate shortened directly observed treatment (DOTS) for management of pulmonary tuberculosis and to compare its outcomes with self-administered therapy (SAT). Material and Methods: Evaluation of DOTS, implemented since 1998, was compared with a cohort of pulmonary tuberculosis patients under SAT from 1992 to 1997. Efficacy and efficiency of treatment were evaluated to agree with the National Tuberculosis Control Program. The study was conducted at a primary health care center in Hermosillo, Sonora, Mexico. Results: One hundred thirty eight patients with smear-positive pulmonary tuberculosis were included, 45 in DOTS cohort and 93 in SAT Efficiency was higher in DOTS-managed cases compared with SA T cohort (95.5% vs 76.3%), p <0.05. Indeed, efficiency was significantly higher in relapsed patients treated under DOTS, p <0.05. The non-compliance rate declined to 0.0% in the DOTS cohort. Twenty six percent of DOTS patients were supervised as outpatients. Conclusions: Implementation of DOTS was a flexible and effective strategy in treatment of pulmonary tuberculosis. DOTS allows treatment completion, decline in non-compliance, and increase in care rate.

Palavras-chave : Pulmonary tuberculosis; directly observed therapy/DOTS; Mexico.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons